Correlation Between OncoCyte Corp and Evolus
Can any of the company-specific risk be diversified away by investing in both OncoCyte Corp and Evolus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoCyte Corp and Evolus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoCyte Corp and Evolus Inc, you can compare the effects of market volatilities on OncoCyte Corp and Evolus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoCyte Corp with a short position of Evolus. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoCyte Corp and Evolus.
Diversification Opportunities for OncoCyte Corp and Evolus
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between OncoCyte and Evolus is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding OncoCyte Corp and Evolus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evolus Inc and OncoCyte Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoCyte Corp are associated (or correlated) with Evolus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evolus Inc has no effect on the direction of OncoCyte Corp i.e., OncoCyte Corp and Evolus go up and down completely randomly.
Pair Corralation between OncoCyte Corp and Evolus
Considering the 90-day investment horizon OncoCyte Corp is expected to under-perform the Evolus. In addition to that, OncoCyte Corp is 1.26 times more volatile than Evolus Inc. It trades about 0.0 of its total potential returns per unit of risk. Evolus Inc is currently generating about 0.06 per unit of volatility. If you would invest 957.00 in Evolus Inc on September 4, 2024 and sell it today you would earn a total of 394.00 from holding Evolus Inc or generate 41.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
OncoCyte Corp vs. Evolus Inc
Performance |
| Timeline |
| OncoCyte Corp |
| Evolus Inc |
OncoCyte Corp and Evolus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with OncoCyte Corp and Evolus
The main advantage of trading using opposite OncoCyte Corp and Evolus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoCyte Corp position performs unexpectedly, Evolus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolus will offset losses from the drop in Evolus' long position.| OncoCyte Corp vs. Candel Therapeutics | OncoCyte Corp vs. Anebulo Pharmaceuticals | OncoCyte Corp vs. Cingulate Warrants | OncoCyte Corp vs. Unicycive Therapeutics |
| Evolus vs. Collegium Pharmaceutical | Evolus vs. Phibro Animal Health | Evolus vs. ANI Pharmaceuticals | Evolus vs. Procaps Group SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |